Octane's 4th Annual Cardiovascular Tech Forum to Feature More Than 50 Experts Who Share Latest Developments and Innovations in Cardiovascular Healthcare Sept. 11-12

Two-Day Forum Offers an Opportunity to Network with Industry Leaders Exploring the Future of Cardiovascular Technology, Reviewing Its Breakthroughs, Evaluating the Advanced Solutions Shaping the Sector, and Appraising Investment Opportunities

NEWPORT BEACH, Calif., July 14, 2025 /PRNewswire/ -- Octane, Southern California's leading organization dedicated to driving innovation, is proud to announce its 2025 4^th annual Cardiovascular Tech Forum September 11-12, 2025, at the VEA Newport Beach.

The forum lineup features more than 50 national experts and innovators who will share their expertise on groundbreaking advancements in cardiovascular technology. Attendees will hear from professionals in the field and gain early insights into emerging investment trends in the latest technologies.

Addressed will be multiple aspects of the newly emerging frontiers in cardiovascular medicine and potential investment opportunities. The future of cardiovascular medicine and current interventional heart failure approaches, such as tricuspid intervention, will be highlighted as well as the impact of government on the cardiovascular industry. The tech forum will introduce highly vetted select companies to introduce their products to the Octane investor ecosystem with key strategics and physicians

The event will be emceed by Darshana Zaveri, founder and managing partner of Catalyst Health Ventures (CHV). She has led several investments in the medical device, women's health and diagnostics markets in addition to being actively involved in all aspects of fund management including investments and capital raising. She currently represents or has  previously represented CHV on the boards of Augmenix, nVision Medical, Maxwell Health, Aria CV, PanTher Therapeutics, AtaCor Medical, Instylla, Avive, Rejoni and Venova Medical.

The keynote speaker will be John Simpson, M.D., MS, PhD. Dr. Simpson has revolutionized the field of medicine through a variety of innovations that have fundamentally altered how physicians treat cardiovascular disease. Dr. Simpson has started numerous companies dedicated to providing patients with novel therapies in a variety of different areas, including directional atherectomy (coronary and peripheral), chronic total occlusions (CTOs), ultrasound, percutaneous transluminal coronary angioplasty, suture-mediated vascular closure, and local drug delivery.

Of special note, the Pediatric Innovations in Cardiovascular Medicine Panel will be moderated by Mike Mussallem, former Chairman and CEO, Edwards Lifesciences and co-founder of The Linda and Mike Mussallem Foundation.

Additionally, forum judges will hear capital and growth presentation pitches from eight cardiovascular tech entrepreneurs on stage. The judge's winner will receive an American Heart Association Innovation Network Membership Award, valued at $25,000.

This year's top sponsors are three organizations central to cardiovascular care: the American Heart Association, Edwards Lifesciences and inQB8 Medical Technologies. Additional sponsors include Additional Ventures, Device Alliance, HBA, Knobbe Martens, Miller Geer and Associates, OCRA-DG, Stradling, Syprosoft, and UC Irvine.

Tickets for the Cardiovascular Tech Forum are still available. Don't miss the chance to engage face-to-face with industry pioneers, discover groundbreaking cardiovascular innovations, and explore investment opportunities that could shape the future of medicine. Register at the link below now.

If you are a practicing physician or investor, contact [email protected] for your complimentary admission.

Event Details:

• Date: September 11-12, 2025
• Location: VEA Newport Beach, Calif.
• Registration: Secure your spot now at: https://www.octane-oc.org/event/CTF/summary

About Octane
Octane accelerates innovation by connecting entrepreneurs, investors, and industry leaders across Southern California. Its forums annually engage thousands, fostering growth within the tech and MedTech ecosystems. The Cardiovascular Tech Forum continues this tradition, uniting global cardiovascular innovators to inspire future advancements.

SOURCE Octane